MediLink-Global seeks cancellation from AIM

MediLink-Global announced on Wednesday that it has decided to seek shareholder approval for the cancellation of the company's ordinary shares from trading on AIM.

The directors of the AIM-traded firm said they consider that the costs associated with having its shares admitted to trading on AIM are not commensurate with the associated benefits of Admission.

“The company intends to convene a general meeting shortly, at which it will propose a resolution to approve the cancellation in accordance with Rule 41 of the AIM Rules for Companies,” MediLink’s board said in a statement.

“For cancellation to become effective, the company will require not less than 75% of the votes cast by shareholders on the resolution to be in favour of approving the cancellation at the general meeting.”